News & Updates

Initiation of hormone therapy during menopause or in recently postmenopausal women with vasomotor symptoms helps lower the risk of cardiovascular disease (CVD), according to a study.

In patients with schizophrenia or schizoaffective disorder who are scheduled to undergo electroconvulsive therapy (ECT), the presence of anxiety symptoms at baseline is associated with reduced ECT efficacy, as shown in a study.

A novel prescription delivery programme (PDP) appears to significantly reduce glycated haemoglobin levels (HbA1c) in patients with diabetes mellitus (DM), suggests a study.

Among kidney transplant recipients, the risk of bleeding is comparable between patients treated with warfarin and those treated with direct oral anticoagulants (DOACs), a study has shown.

A real-world study from Spain demonstrates the efficacy and safety of Kalinix^®, a novel device for the management of obstructive sleep apnoea (OSA).

Oral administration of the bacterial lysate OM-85 in early life does not appear to reduce the incidence of wheezing lower respiratory tract illness during the preschool years, according to the parallel-arm, double-blind, placebo-controlled ORBEX trial.

Researchers at the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, have developed and validated a clinical prognostic model incorporating age, tumour (T), nodal (N) stage, and chemotherapy to predict survival outcomes in patients with early-stage medullary breast cancer (medBC).

In patients hospitalized for heart failure (HF), losing at least 2 kg of weight while receiving treatment with intravenous loop diuretic may be a good prognostic signal, being associated with reduced 30-day risk of HF rehospitalization regardless of renal function status, as shown in a study.